Adherence logger for a dry powder inhaler: a new device for medical adherence research.

BACKGROUND Adherence to inhaled steroid regimens is frequently poor. Finding ways to improve adherence depends on the ability to measure time and date of inhaler use reliably and to detect deliberate dose dumping. There is no such monitor for the popular new dry powder inhalers. OBJECTIVE To develop and test an electronic monitor for a dry powder inhaler that will provide information on the time and date of use. METHODS An electronic adherence monitor for the Advair Diskus dry powder inhaler was developed and tested. In this device, inhaler use is determined by detecting and recording the motion of the drug delivery lever in the inhaler with a magnetic sensor. An additional electronic interface and software were also developed to allow the adherence data to be uploaded to a computer for display and analysis. RESULTS System and reliability tests involving multiple-day and repeated-use tests of the adherence monitor demonstrate the overall performance and reliability of the device, and specifically its ability to record the time and date of dose delivery. In the repeated-use test, 300 successive actuations of the dose delivery lever were correctly sensed and recorded without error. CONCLUSION The simple-to-use, low-cost, reusable adherence monitor accurately records time and date of inhaler use and thus allows clinical monitoring and adherence studies in patients using the Advair Diskus dry powder inhaler. The same technology should be adaptable to other dry powder inhalers, including the Pulmicort Tubuhaler and the Symbicort Tubuhaler.

[1]  A. Woodcock,et al.  Chlorofluorocarbon-free inhalers: are we ready for the change? , 1998, The European respiratory journal.

[2]  A. Wu,et al.  Treatment patterns among adult patients with asthma: factors associated with overuse of inhaled beta-agonists and underuse of inhaled corticosteroids. , 1999, Archives of internal medicine.

[3]  B. Bender,et al.  Adherence intervention research: what have we learned and what do we do next? , 2003, The Journal of allergy and clinical immunology.

[4]  Robert A. Wise,et al.  Metered-dose inhaler adherence in a clinical trial. , 1992, The American review of respiratory disease.

[5]  Harold I Feldman,et al.  Modifiable barriers to adherence to inhaled steroids among adults with asthma: it's not just black and white. , 2003, The Journal of allergy and clinical immunology.

[6]  R. Zuwallack,et al.  Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. , 1998, American journal of respiratory and critical care medicine.

[7]  G. O'Connor,et al.  Poverty, race, and medication use are correlates of asthma hospitalization rates. A small area analysis in Boston. , 1995, Chest.

[8]  M. Cowles,et al.  Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. , 1995, American journal of respiratory and critical care medicine.

[9]  C. Rand,et al.  Noncompliance and treatment failure in children with asthma. , 1996, The Journal of allergy and clinical immunology.

[10]  S. Suissa,et al.  Inhaled corticosteroids: impact on asthma morbidity and mortality. , 2001, The Journal of allergy and clinical immunology.

[11]  C. Rand,et al.  Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. , 1993, The American journal of cardiology.